Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions.

Wang Y, Liu M, Gao J. · 2020

Read Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions. by Wang Y, Liu M, Gao J. (2020) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/europmc-pmc7322019.txt.

Introduction

Wang, Liu and Gao explain, atom by atom, why SARS-CoV-2 grips its human receptor more tightly than the earlier SARS virus. Their study appeared in the Proceedings of the National Academy of Sciences. Stronger binding to ACE2 is thought to help drive the new virus's high contagiousness. The spike proteins of the two viruses are 76% identical, so the difference hides in small details.

Using molecular dynamics and binding energy calculations, the team mapped the hydrogen bonds and water-shunning contacts at the interface. SARS-CoV-2's reported binding strength exceeds its predecessor's by a factor of 10 to 15. The new contact network balances specific and nonspecific interactions to achieve that grip. Such structural detail can guide surveillance of new variants and the design of agents that block or neutralize the binding surface.

Catalog record

CREATORWang Y, Liu M, Gao J.
YEAR2020
COLLECTIONPAPERS
FORMATTXT
FILE SIZE40 KB
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC7322019

Browse the full library · About the Tower of Babel

Full text

The opening of the work, from the library's hosted text:

Enhanced receptor binding of SARS-CoV-2 through networks of hydrogen-bonding and hydrophobic interactions By Yingjie Wang, Meiyi Liu, Jiali Gao Published in: Proceedings of the National Academy of Sciences of the United States of America DOI: 10.1073/pnas.2008209117 ABSTRACT Significance Enhanced receptor binding by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is believed to contribute to the highly contagious transmission rate of coronavirus disease 2019. An understanding of the structural and energetic details responsible for protein–protein interactions between the host receptor ACE2 and SARS-CoV-2 can be useful to epidemic surveillance, diagnosis, and optimization of neutralizing agents. The present study unravels a delicate balance of specific and nonspecific hydrogen-bonding and hydrophobic networks to help elucidate the similarities and differences in receptor binding by SARS-CoV-2 and SARS-CoV. Keywords: protein–protein interaction, SARS-CoV-2, relative free energy of binding, molecular dynamics The novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that causes the current outbreak of coronavirus disease 2019 (COVID-19) shares many similarities with the SARS coronavirus in 2002–2003 (SARS-CoV), including 76% sequence identity in the spike protein (S) (1–3), a common receptor of the angiotensin converting enzyme 2 (ACE2) (4–6), and the fusion mechanism that involves cleavages of spike at the S1–S2 and S2ʹ sites (7). Amino acid mutations critical to protein–protein interactions have been identified to play a critical role in human-to-human as well as cross-species transmissions (8, 9). Furthermore, it has been reported that the affinity constant for the receptor binding domain (RBD) of SARS-CoV-2 to ACE2 is greater than that of SARS-CoV by as much as a factor of 10 to 15 (10, 11), and the furin recognition sequence “RRAR” at the S1–S2 cleaving site of SARS-CoV-2 represents a near-optimal match for the cellular serine protease TMPRSS2 (5, 12, 13). Both factors likely contribute to the efficiency of virus transmission, making COVID-19 more contagious than infections by SARS-CoV and the influenza virus. Curiously, a SARS-CoV neutralizing antibody, 80R, that recognizes the S protein with nanomolar affinity (14) in the same interfacial region of ACE2 does not show detectable binding to the RBD of SARS-CoV-2 (11, 15). What mutations in the 2019 novel coronavirus make it a stronger binder to ACE2 than SARS-CoV, but, at the same time, capable of evading the antibody against SARS-CoV? An understanding of the underlying mechanisms for protein–protein association between the ACE2 receptor and the RBD of SARS-CoV-2 as well as the difference from that of SARS-CoV is important for virus detection, epidemic surveillance and prevention, and vaccine and inhibitor design. In this study, we present findings from molecular dynamics (MD) simulations of binary complexes of the RBD domains of both the SARS and COVID-19 viruses with the common receptor ACE2 and the antibody 80R. The present simulations reveal that both electrostatic complementarity and hydrophobic interactions are critical to enhancing receptor binding and escaping antibody recognition by the RBD of SARS-CoV-2. RESULTS Electrostatic Complementarity Is Enhanced in the RBD–ACE2 Complex of SARS-CoV-2. The amino acid sequence of the RBD of SARS-CoV-2 (residue numbers 335 to 515) is highly homologous to that of the SARS-CoV with a single amino acid insertion (Val483) at the edge of the binding interface. Throughout this paper, we use the SARS-CoV-2 sequence number in the discussion and point out the corresponding number for SARS-CoV using a subscript “s.” RBD is structurally divided into a core region, consisting of five antiparallel strands of β-sheet, which is relatively conserved (87.4% sequence identity), and a more variable (50% homology) receptor binding motif (RBM) (SI Appendix, Fig. S1). Sequence variations mainly aggregate in the loop regions, two of which are located at both ends of the dimer contact region, denoted as CR1 and CR3 (Fig. 1A). Crystal structures show that both RBDs of SARS-CoV-2 and SARS-CoV have the same scaffold (11, 16–18). The middle region in the protein–protein interface (CR2) consists of two short strands of β-sheets bridging across the N-terminal helix of ACE2. While CR3 mainly involves charge-preserving mutations from SARS-CoV to SARS-CoV-2, sequence alterations in the other two regions affect surface electrostatics (Fig. 1B). Notably, the V404s→K417 conversion in the 2019 novel coronavirus creates a positive electrostatic patch along with R403 and R408. This change leads to a complementary match with the negative potential from Asp30 over the binding surface of ACE2 (Fig. 1B). On the other hand, changes in the CR1 region, including E471(V458s), T478(K465s), and E484(P470s), enhance the negative potential relative to that of SARS-CoV (Fig. 1B). Overall, the sequence differences in the RBM enable greater electrostatic complementarity with the receptor ACE2 in SARS-CoV-2 complex than that of SARS-CoV. [Figure: Crystal structures (A) and computed electrostatic potentials (B) of ACE2 and the RBD. In A, the RBD–ACE2 complex is shown (Left), along with the designation of binding contact regions CR1, CR2, and CR3 for the RBD of SARS-CoV-2 (Center) and SARS-CoV (Right); the RBM is colored in yellow, and key residues are shown in stick model. The contact residues in ACE2 is colored in red. In B, the van der Waals surface of residues within 3.8 Å between RBD and receptor atoms are colored blue to indicate positive potential and red for negative potential. Crystal structures (PDB ID codes 6LZG and 6ACG) are used for the schematic depiction.] Electrostatic Complementarity Induces Conformational Shift. Analyses of the trajectories from MD simulations of the binary complexes between ACE2 and the RBDs of both SARS-CoV-2 and SARS-CoV, each lasting 200 ns, reveal that RBD and ACE2 undergo symmetric twist and antisymmetric hinge-bending motions about the axis of the N-terminal helix, corresponding to the lowest quasiharmonic modes, PC1 and PC2, from principal component analysis (Fig. 2A). Although the overall conformation dynamics are the same in the two complexes, the average conformation of the SARS-CoV-2 structure is in fact shifted relative to that of SARS-CoV (Fig. 2C) when the dynamic configurations are projected onto the two principal vectors. This translates to a net bending of the RBD by about 6° toward the ACE2 binding cleft in the SARS-CoV-2 complex (Fig. 2D), while the average configuration of the SARS-CoV is close to the initial crystal structure. Interestingly, comparison of the crystal structures of the two complexes does not show this small but significant conformational difference, perhaps due to crystal packing restraint. Consistent with electrostatic potential complementarity and structural details (discussed below), the observed conformation shift may be attributed to the formation of a salt bridge between Asp30 of ACE2 and Lys417 across the binding groove, along with strengthened loop-anchoring interactions at the bases of the binding interface. The salt bridge is absent in the SARS-CoV complex in which the corresponding Val404s is not in direct contact with ACE2. [Figure: Characteristic dynamic fluctuations of the RBD–ACE2 complexes of SARS-CoV-2 and SARS-CoV depicted by the two lowest-frequency principal components (PC1 and PC2) in A, and dynamic conformations projected on to the two principal vectors (C). (B) The rmsd and contact areas of the receptor-binding motif in both complexes during the 200-ns MD simulations. (D) The tilt angles of the two RBD–ACE2 complexes, defined by vectors from the Cα atom of His34 near the center of the N-terminal helix to the centers of mass (C.O.M) for RBD and ACE2, respectively.] Overall, we find that the RBM of SARS-CoV-2 has a relatively smaller root-mean-square

Read the complete text